Transcript Document

The Story of Bcl-2
Linking cell apoptosis to tumor
metastasis
Crystal structure of Bcl-2 complex
By Yaming Wang
History

Bcl-2 was first isolated
in B Cell Lymphoma
cells


Caused by malignant B
lymphocytes
Contributes about 85% of
known types of
lymphoma in US
Immunofluorescence stain of
B cells in the spleen
(green= Bcl-2)
History continued

The mutation of Bcl-2 was due to chromosome
translocation

Very similar to the story of Cyclin D as an oncogene
Mistake happens during BCR
(VDJ) rearrangement
Bcl-2 gene (from chromosome 14) is
placed next to Ig heavy chain locus on
chromosome 18
 This leads to the overexpression of Bcl2 in B cells

But what is the mechanism
that makes Bcl-2 a killer?
Bcl family proteins govern
programmed cell death (apoptosis)
Bcl-2 protein Biochemistry




Bcl-2 is a small protein (~29KD)
Bcl family proteins play crucial role in cell
apoptosis
Divided into pro-survival and pro-apoptosis and
usually balance each other out in healthy cells
Bcl-2 is a pro-survival protein and it protects cell
from a wide range of cytotoxic insults, including
cytokine deprivation, UV and -irradiation
Highly conserved BH domains



Bcl family proteins share
highly conserved regions
called Bcl homology
(BH) domain
Structurally, divided into 3
families
BH3-only family proteins
bind to pro-survival family
proteins at the groove
formed by BH1, BH2, and
BH3 domains

Binding triggers the switch
of apoptosis signaling
Proposed Mechanism
- protection of mitochondrial integrity by Bcl-2
Bcl proteins are highly regulated
In response to different signal (ie. Death,
or proliferation), Bcl family proteins are up/
down regulated.
 Example: Regulation of T lymphocytes

In response to the immunosuppression
signal, Bcl-XL level is down regulated.
Yaming Wang, unpublished data, Microbiology and Immunology, 2006
What happen if Bcl-2 is
over expressed or knocked
out in mice?
What happen if Bcl-2 is over expressed or knocked
out in mice?

Bcl-2 over expressing mice:


B cell lymphomas are frequently found
Bcl-2 knock out mice:
Viable but show growth retardation
 Severe polycystic kidney disease
 Massive apoptotic involution in thymus and
spleen

Linking anti-apoptosis to tumor
metastasis

Bcl-2 is also over expressed in many
cancers including lung, colorectal,
prostate, and breast, as well as in
leukemia and other lymphomas

Several changes are
required
 Eg.
they have to lose their
dependence to local
growth factors, ability to
survive without integrin
signals


All these changes normally
lead to cell apoptosis
Overcome by
overexpressing prosurvival Bcl family proteins
Alberts et al.
Fig. 24-16
Recent studies have shown that prolonged
cell survival induced by the overexpression
of Bcl-2 protein promotes the metastasis of
many cancer cells such as melanoma cells
and mammary epithelial cells.
 Therefore, it maks Bcl protein a very good
target for cancer therapy.

References






The lymphoma information network. http://www.LymphomaInfo.net/
Veis D.J., Sorenson C.M., Bcl-2-deficient mice demostrate fulminant
lymphod apoptosis, polycystic kidneys, and hypopigmented hiar,
Cell, 75, 2, 1993 229-240
Pinkas J., Martin S.S., Bcl-2-mediated cell survival promotes
metastasis of EpH4 BMEKDD mammary epithelial cells, Mol Cancer
Res; 2(10), 2004
Anderson M.H., Svane I.M., Immunogenicity of Bcl-2 in patients with
cancer, Blood, 105, 2, 2005
Takaoka A., Adachi M., Anti-cell death activity protomtes pulmonary
metastasis of melanoma cells, Oncogen, 14, 1997, 2971-2977
Cory S., Adams J.M., The Bcl-2 family: regulators of the cellular lifeor-death switch, Nature, 2, 2002, 647-656
Thank you very much!
Have a good Spring Break!
Cancer therapies targeting Bcl-2
over expression




Some drugs that inhibit Bcl-2 by BH3 mimetics
Antisense oligonucleotide (inhibit mRNA translation)
More interestingly, shown that Bcl-2 over expression is in
fact immunogenic. (meaning we can generate immunity
against cells in which Bcl-2 is over expressed. ie. cancer
cells.)
This gives us a way to target cancer cells using the
weapons in our body (immune system) without harming
healthy cells in cancer therapy.